NBI ..
-
Stærk start på dagen og øget chance for "take off" i vores "cup with handle" model. Dayli: https://invst.ly/p47xy - weekly: https://invst.ly/p47zk
-
Bang deropad - jeg håber I er godt lastet i biotech derude !
-
Her TA fra mesteren (@alpenyt) selv.
Top 10 udgoer cirka 50% af vaerdien. Amgen, som udgoer 8-9%, var billig tidligere i aar, men er steget en del i H2. Jeg har kun fidus til Gilead (7-8%) og Biogen (5%) nu hvad angaar koeb.
Biomarin udgoer 2% af den samlede vaerdi og er den mindste blandt top 10:
https://www.biomarin.com/about
Biomarin har blandt andet Vosoritide i pipeline:
https://www.biomarin.com/products/pipeline/bmn-111/
Vosoritide is designed for the treatment of achondroplasia, the most common form of dwarfism.
BioMarin Announces Cumulative Additional Height Gain of 9.0 cm over 54 months versus Natural History in Children with Achondroplasia Treated with Vosoritide in Phase 2 Study
https://investors.biomarin.com/2019-11-14-BioMarin-Announces-Cumulative-Additional-Height-Gain-of-9-0-cm-over-54-months-versus-Natural-History-in-Children-with-Achondroplasia-Treated-with-Vosoritide-in-Phase-2-StudySeattle Genetics er stukket helt af. De samarbejder i en europaeisk kontekst bl.a. med Genmab om Tisotumab Vedotin (aeggestokke-kraeft og livmoderhals-kraeft):
https://www.seattlegenetics.com/pipeline/tisotumab-vedotin
http://www.genmab.com/product-pipeline/products-in-development/humax-tf-adc
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind